Cargando…
Efficacy and Safety of Intravenous Thrombolysis on Acute Branch Atheromatous Disease: A Retrospective Case–Control Study
Background and Objective: Branch atheromatous disease (BAD) is distinctive from large-artery atherosclerosis and small-vessel disease, which is single subcortical infarction caused by the occlusion of perforator's orifice. This study aimed to indicate whether intravenous thrombolysis (IVT) with...
Autores principales: | Wu, Xiangbo, Liu, Yang, Nie, Chuang, Kang, Zhiming, Wang, Qunfeng, Sun, Dong, Li, Huagang, Liu, Yumin, Mei, Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7358343/ https://www.ncbi.nlm.nih.gov/pubmed/32733357 http://dx.doi.org/10.3389/fneur.2020.00581 |
Ejemplares similares
-
Early administration of tirofiban after urokinase-mediated
intravenous thrombolysis reduces early neurological deterioration in patients
with branch atheromatous disease
por: Liu, Bin, et al.
Publicado: (2020) -
Influencing factors of early dramatic recovery of neurological function after intravenous thrombolysis in patients with branch atheromatous disease
por: Meng, Yuanyuan, et al.
Publicado: (2023) -
Serum uric acid to serum creatinine ratio predicts neurological deterioration in branch atheromatous disease
por: Liu, Yinglin, et al.
Publicado: (2023) -
Branch atheromatous disease and treatment
por: Duan, Honglian, et al.
Publicado: (2022) -
Safety and Efficacy of Tirofiban During Intravenous Thrombolysis Bridging to Mechanical Thrombectomy for Acute Ischemic Stroke Patients: A Meta-Analysis
por: Li, Wei, et al.
Publicado: (2022)